 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, January 15, 2000, 20(2):639-648
Identification and Characterization of proSAAS, a Granin-Like Neuroendocrine Peptide Precursor that Inhibits Prohormone Processing
Lloyd D. Fricker1, Audra A. McKinzie2, Jilin Sun2, Eileen Curran2, Yimei Qian1, Lin Yan1, Scott D. Patterson3, Paul L. Courchesne3, Bill Richards2, Nancy Levin2, Nino Mzhavia4, Lakshmi A. Devi4, and James Douglass2 1 Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, Departments of 2 Neuroendocrinology and 3 Mammalian Genomics, Amgen, Thousand Oaks, California 91360-1789, and 4 Department of Pharmacology, New York University School of Medicine, New York, New York 10016
Five novel peptides were identified in the brains of mice lacking active carboxypeptidase E, a neuropeptide-processing enzyme. These peptides are produced from a single precursor, termed proSAAS, which is present in human, mouse, and rat. ProSAAS mRNA is expressed primarily in brain and other neuroendocrine tissues (pituitary, adrenal, pancreas); within brain, the mRNA is broadly distributed among neurons. When expressed in AtT-20 cells, proSAAS is secreted via the regulated pathway and is also processed at paired-basic cleavage sites into smaller peptides. Overexpression of proSAAS in the AtT-20 cells substantially reduces the rate of processing of the endogenous prohormone proopiomelanocortin. Purified proSAAS inhibits prohormone convertase 1 activity with an IC50 of 590 nM but does not inhibit prohormone convertase 2. Taken together, proSAAS may represent an endogenous inhibitor of prohormone convertase 1.
Key words: carboxypeptidase E; prohormone convertase; 7B2; secretogranin; chromogranin; neuropeptide
Copyright © 2000 Society for Neuroscience 0270-6474/00/202639-10$05.00/0
This article has been cited by other articles:
L. F. Waanders, K. Chwalek, M. Monetti, C. Kumar, E. Lammert, and M. Mann
Quantitative proteomic analysis of single pancreatic islets
PNAS, November 10, 2009; 106(45): 18902 - 18907.
[Abstract] [Full Text] [PDF]
H. Kudo, J. Liu, E. J. R. Jansen, A. Ozawa, P. Panula, G. J. M. Martens, and I. Lindberg
Identification of proSAAS Homologs in Lower Vertebrates: Conservation of Hydrophobic Helices and Convertase-Inhibiting Sequences
Endocrinology, March 1, 2009; 150(3): 1393 - 1399.
[Abstract] [Full Text] [PDF]
N. G. Hatcher, N. Atkins Jr., S. P. Annangudi, A. J. Forbes, N. L. Kelleher, M. U. Gillette, and J. V. Sweedler
Mass spectrometry-based discovery of circadian peptides
PNAS, August 26, 2008; 105(34): 12527 - 12532.
[Abstract] [Full Text] [PDF]
L. E. Pritchard and A. White
Neuropeptide Processing and Its Impact on Melanocortin Pathways
Endocrinology, September 1, 2007; 148(9): 4201 - 4207.
[Abstract] [Full Text] [PDF]
E. A. Nillni
Regulation of Prohormone Convertases in Hypothalamic Neurons: Implications for ProThyrotropin-Releasing Hormone and Proopiomelanocortin
Endocrinology, September 1, 2007; 148(9): 4191 - 4200.
[Abstract] [Full Text] [PDF]
S. S. Gouraud, K. Heesom, S. T. Yao, J. Qiu, J. F. R. Paton, and D. Murphy
Dehydration-Induced Proteome Changes in the Rat Hypothalamo-Neurohypophyseal System
Endocrinology, July 1, 2007; 148(7): 3041 - 3052.
[Abstract] [Full Text] [PDF]
M. Fugere, J. Appel, R. A. Houghten, I. Lindberg, and R. Day
Short Polybasic Peptide Sequences Are Potent Inhibitors of PC5/6 and PC7: Use of Positional Scanning-Synthetic Peptide Combinatorial Libraries as a Tool for the Optimization of Inhibitory Sequences
Mol. Pharmacol., January 1, 2007; 71(1): 323 - 332.
[Abstract] [Full Text] [PDF]
N. Scamuffa, F. Calvo, M. Chretien, N. G. Seidah, and A.-M. Khatib
Proprotein convertases: lessons from knockouts
FASEB J, October 1, 2006; 20(12): 1954 - 1963.
[Abstract] [Full Text] [PDF]
J. R. Peinado, R. Vazquez-Martinez, D. Cruz-Garcia, A. Ruiz-Navarro, Y. Anouar, M. C. Tonon, H. Vaudry, F. Gracia-Navarro, J. P. Castano, and M. M. Malagon
Differential Expression and Processing of Chromogranin A and Secretogranin II in Relation to the Secretory Status of Endocrine Cells
Endocrinology, March 1, 2006; 147(3): 1408 - 1418.
[Abstract] [Full Text] [PDF]
G. Schmidt, F. Sirois, Y. Anini, L. M. Kauri, C. Gyamera-Acheampong, E. Fleck, F. W. Scott, M. Chretien, and M. Mbikay
Differences of Pancreatic Expression of 7B2 Between C57BL/6J and C3H/HeJ Mice and Genetic Polymorphisms at its locus (Sgne1)
Diabetes, February 1, 2006; 55(2): 452 - 459.
[Abstract] [Full Text] [PDF]
M. Hosaka, T. Watanabe, Y. Sakai, T. Kato, and T. Takeuchi
Interaction between secretogranin III and carboxypeptidase E facilitates prohormone sorting within secretory granules
J. Cell Sci., October 15, 2005; 118(20): 4785 - 4795.
[Abstract] [Full Text] [PDF]
F.-Y. Che, J. Lim, H. Pan, R. Biswas, and L. D. Fricker
Quantitative Neuropeptidomics of Microwave-irradiated Mouse Brain and Pituitary
Mol. Cell. Proteomics, September 1, 2005; 4(9): 1391 - 1405.
[Abstract] [Full Text] [PDF]
F.-Y. Che, Q. Yuan, E. Kalinina, and L. D. Fricker
Peptidomics of Cpefat/fat Mouse Hypothalamus: EFFECT OF FOOD DEPRIVATION AND EXERCISE ON PEPTIDE LEVELS
J. Biol. Chem., February 11, 2005; 280(6): 4451 - 4461.
[Abstract] [Full Text] [PDF]
X. Shen, Q.-L. Li, G. A. Brent, and T. C. Friedman
Regulation of regional expression in rat brain PC2 by thyroid hormone/characterization of novel negative thyroid hormone response elements in the PC2 promoter
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E236 - E245.
[Abstract] [Full Text] [PDF]
V. Valverde-Garduno, B. Guyot, E. Anguita, I. Hamlett, C. Porcher, and P. Vyas
Differences in the chromatin structure and cis-element organization of the human and mouse GATA1 loci: implications for cis-element identification
Blood, November 15, 2004; 104(10): 3106 - 3116.
[Abstract] [Full Text] [PDF]
L. E. Pritchard, R. L. Oliver, J. D. McLoughlin, S. Birtles, C. B. Lawrence, A. V. Turnbull, and A. White
Proopiomelanocortin-Derived Peptides in Rat Cerebrospinal Fluid and Hypothalamic Extracts: Evidence that Secretion Is Regulated with Respect to Energy Balance
Endocrinology, March 1, 2003; 144(3): 760 - 766.
[Abstract] [Full Text] [PDF]
G. A. Cornwall, A. Cameron, I. Lindberg, D. M. Hardy, N. Cormier, and N. Hsia
The Cystatin-Related Epididymal Spermatogenic Protein Inhibits the Serine Protease Prohormone Convertase 2
Endocrinology, March 1, 2003; 144(3): 901 - 908.
[Abstract] [Full Text] [PDF]
E. A. Nillni, W. Xie, L. Mulcahy, V. C. Sanchez, and W. C. Wetsel
Deficiencies in Pro-thyrotropin-releasing Hormone Processing and Abnormalities in Thermoregulation in Cpefat/fatMice
J. Biol. Chem., December 6, 2002; 277(50): 48587 - 48595.
[Abstract] [Full Text] [PDF]
A.-M. Khatib, G. Siegfried, M. Chretien, P. Metrakos, and N. G. Seidah
Proprotein Convertases in Tumor Progression and Malignancy : Novel Targets in Cancer Therapy
Am. J. Pathol., June 1, 2002; 160(6): 1921 - 1935.
[Abstract] [Full Text] [PDF]
Y. Fortenberry, J.-R. Hwang, E. V. Apletalina, and I. Lindberg
Functional Characterization of ProSAAS. SIMILARITIES AND DIFFERENCES WITH 7B2
J. Biol. Chem., February 8, 2002; 277(7): 5175 - 5186.
[Abstract] [Full Text] [PDF]
C. Grundschober, F. Delaunay, A. Puhlhofer, G. Triqueneaux, V. Laudet, T. Bartfai, and P. Nef
Circadian Regulation of Diverse Gene Products Revealed by mRNA Expression Profiling of Synchronized Fibroblasts
J. Biol. Chem., December 7, 2001; 276(50): 46751 - 46758.
[Abstract] [Full Text] [PDF]
E. Lanoue and R. Day
Coexpression of Proprotein Convertase SPC3 and the Neuroendocrine Precursor ProSAAS
Endocrinology, September 1, 2001; 142(9): 4141 - 4149.
[Abstract] [Full Text] [PDF]
R. G. Allen, B. Peng, M. J. Pellegrino, E. D. Miller, D. K. Grandy, J. R. Lundblad, C. L. Washburn, and J. E. Pintar
Altered Processing of Pro-Orphanin FQ/Nociceptin and Pro-Opiomelanocortin-Derived Peptides in the Brains of Mice Expressing Defective Prohormone Convertase 2
J. Neurosci., August 15, 2001; 21(16): 5864 - 5870.
[Abstract] [Full Text] [PDF]
F.-Y. Che, L. Yan, H. Li, N. Mzhavia, L. A. Devi, and L. D. Fricker
Identification of peptides from brain and pituitary of Cpefat/Cpefat mice
PNAS, July 24, 2001; (2001) 161542198.
[Abstract] [Full Text] [PDF]
Y. Qian, L. A. Devi, N. Mzhavia, S. Munzer, N. G. Seidah, and L. D. Fricker
The C-terminal Region of proSAAS Is a Potent Inhibitor of Prohormone Convertase 1
J. Biol. Chem., July 28, 2000; 275(31): 23596 - 23601.
[Abstract] [Full Text] [PDF]
A. Cameron, J. Appel, R. A. Houghten, and I. Lindberg
Polyarginines Are Potent Furin Inhibitors
J. Biol. Chem., November 17, 2000; 275(47): 36741 - 36749.
[Abstract] [Full Text] [PDF]
Y. Berman, N. Mzhavia, A. Polonskaia, and L. A. Devi
Impaired Prohormone Convertases in Cpefat/Cpefat Mice
J. Biol. Chem., January 5, 2001; 276(2): 1466 - 1473.
[Abstract] [Full Text] [PDF]
N. Mzhavia, Y. Berman, F.-Y. Che, L. D. Fricker, and L. A. Devi
ProSAAS Processing in Mouse Brain and Pituitary
J. Biol. Chem., February 23, 2001; 276(9): 6207 - 6213.
[Abstract] [Full Text] [PDF]
A. Basak, P. Koch, M. Dupelle, L. D. Fricker, L. A. Devi, M. Chretien, and N. G. Seidah
Inhibitory Specificity and Potency of proSAAS-derived Peptides toward Proprotein Convertase 1
J. Biol. Chem., August 24, 2001; 276(35): 32720 - 32728.
[Abstract] [Full Text] [PDF]
M. Fugere, P. C. Limperis, V. Beaulieu-Audy, F. Gagnon, P. Lavigne, K. Klarskov, R. Leduc, and R. Day
Inhibitory Potency and Specificity of Subtilase-like Pro-protein Convertase (SPC) Prodomains
J. Biol. Chem., March 1, 2002; 277(10): 7648 - 7656.
[Abstract] [Full Text] [PDF]
F.-Y. Che, L. Yan, H. Li, N. Mzhavia, L. A. Devi, and L. D. Fricker
Identification of peptides from brain and pituitary of Cpefat/Cpefat mice
PNAS, August 14, 2001; 98(17): 9971 - 9976.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|